Dr. Panpan Liu 刘盼盼
Chief Physician
Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical treatment and research for lymphoma, head and neck tumors, and nasopharyngeal carcinoma.
Dr. Liu is a Chief Physician and doctoral supervisor at Sun Yat-sen University Cancer Center, holding a medical degree. Dr. Liu was a visiting scholar at MD Anderson Cancer Center. Research focuses on medical treatment for lymphoma and head and neck tumors. Dr. Liu has published multiple SCI-indexed papers as first or co-first author and leads grants from the National Natural Science Foundation and provincial agencies.
Name order: in Chinese the family name comes first (Liu Panpan). Papers usually list the name as Panpan Liu or Liu P.
Selected publications
73 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Immunol Immunother, 2025 (senior author): Improved efficacy of concurrent anti-PD1 antibody plus AVD versus ABVD in patients with newly diagnosed early unfavorable and advanced stage classic Hodgkin lymphoma: a retrospective matched cohort study. PubMed 40372486
- J Cancer, 2025 (senior author): Radiation Therapy Improves Survival in Patients with Distant Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Study. PubMed 39781346
- Cell Death Differ, 2024 (first author): HKDC1 functions as a glucose sensor and promotes metabolic adaptation and cancer growth via interaction with PHB2. PubMed 39375512
- Redox Biol, 2024 (senior author): The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism. PubMed 38909408
- Haematologica, 2024 (first author): Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations. PubMed 37646669
- Cell Death Discov, 2022 (senior author): Modulation of energy metabolism to overcome drug resistance in chronic myeloid leukemia cells through induction of autophagy. PubMed 35443725
- Front Oncol, 2022 (senior author): The Status and Prospects of Epigenetics in the Treatment of Lymphoma. PubMed 35463343
- Cancers (Basel), 2021 (senior author): Prognostication of Primary Tumor Location in Early-Stage Nodal Diffuse Large B-Cell Lymphoma: An Analysis of the SEER Database. PubMed 34439110
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion